Nanoparticle in vivo characteristics and interactions between nanoparticles and organisms are key components of nanotoxicology.
INTRODUCTION
With the rapid development of nanoscience and nanotechnology, potential risks of materials in nanosize are increasingly important. Some nanomaterials can lead to more severe toxicological effects not invoked by larger size materials of identical chemical composition, by either oral intake [2] [3] [4] [5] [6] or inhalation routine. [7] [8] [9] [10] Fine TiO 2 particles have been widely utilized in cosmetics, antibacterials, paint pigments and decomposing organic matter. The TiO 2 particle's high chemical stability and extremely poor water solubility were thought to render it a nontoxic bio-safety material. Earlier studies indicated that there was no obvious lung toxicity in rats when the single instilled dose of TiO 2 was 5 mg/kg or 50 mg/kg. 11 12 However, many recent studies have demonstrated that inert nanosized TiO 2 particles can be toxic. 13 14 Inhalation of TiO 2 particle in nanoscale (nano-TiO 2 can induce a severe pulmonary inflammatory response. 15 The toxicological effects of nano-TiO 2 particles are size dependent. Oberdörster et al. exposed TiO 2 
particles in different
The in vivo toxicological effects caused by naonparticles are correlated to not only dosage, but also size, specific surface area, nano-structure, and surface characteristics. 17 Chen et al. also showed that the bio-behavior and metabolic path of nanoparticles are dependant on their in vivo 18 aggregation state.
Although the pulmonary toxicological effects of nanoTiO 2 have been identified by many studies via animal models, the specific interactions between particle and organism are still unclear. Recently systematic biological approaches such as genomics, proteomics, and metabonomics have been applied to nanotoxicology research. Metabonomics is a complementary technique that can supply useful information on whole-organism functional integrity over time after exposure. Target organs and related biomarkers can be identified by the change in pattern and level of some endogenous metabolites in biological fluids (like urine and blood). Examining these characteristic changes may imply the possible mechanism of toxicological effects. Nuclear magnetic resonance (NMR) is an advanced spectroscopic technique used to generate metabolomic data sets instead of other teachniques [19] [20] [21] (e.g., liquid chromatography coupled mass spectrometry, tandem and fouriertransform mass spectrometry, capillary electrophoresis and infrared spectroscopy), because 1 HNMR is nonselective in metabolite detection and fit for multiple metabolite quantification and 1 HNMR techniques require minimal sample preparation (about only 400 l) fit for trace analysis. The advantages of NMR-based metabolomic approaches include timesavingness, high sensitivity, non-or less invasiveness and the holistic view of the biochemical variations. Hence, it is quite useful in toxicity evaluations 22 23 and mechanistic toxicological studies. 24 25 In this study, the toxicological effects of nano-TiO 2 were investigated by examining urine obtained from the intratracheally exposed rats using 1 HNMR spectroscopy. Synchronously, blood biochemical assays and histopathological examinations were performed to understand potential liver and kidney toxicities induced by the intratracheal instillation of nano-TiO 2 . Potential toxic biomarkers were identified and the suitability of the metabolomic approach was evaluated.
EXPERIMENTAL DETAILS

Animals and Materials
Male Sprague Dawley rats (provided by the Experimental Animal Center, Nanjing Military General Hospital of PLA), weighing 200 ± 10 g were used in this study. The rats were housed individually in plastic metabolic cages for urine collection. The animals were acclimated in the controlled environment (temperature of 22 ± 1 C, humidity of 60 ± 10% and light/dark cycle of 12 h/12 h) for 5days with free access to nutritionally complete laboratory food and ad libitum water. All animal experiments were performed in compliance with the local ethics committee.
Nanosized TiO 2 particles (herein referred to as "5-nm TiO 2 ") used in this study were purchased from Zhejiang Hongsheng Nano Material Co. Ltd., and the average size is 5 nm in diameter, confirmed by Transmission Electron Microscopy (TEM, Hitachi H-700, Japan). Before use, the 5-nm TiO 2 particles were dispersed into saline solution and diluted to different concentrations of 0.8, 4 and 20 mg/ml, and labeled as low, medium, and high dose. Suspension solutions were treated by ultrasound for 15 minutes before instillation into animals.
Study Protocol In Vivo
The experimental rats were divided into four groups at random (8 rats in each), and anesthetized by 40 mg/kg body weight i p sodium pentobarbital (Solarbio, Germany). Then the treated rats were intratracheally instilled by the suspending solutions with varying doses alongside 1 ml/kg body weight of 5 nm-TiO 2 . And the rats instilled with normal saline (N.S.) in same volume were simultaneously used as a negative control group.
Rat urine was collected from each metabolic cage at predetermined time intervals (−8∼0 h; a 0∼8 h; 8∼24 h; 48∼72 h; 96∼120 h and 144∼168 h). These urine samples were stored in tubes containing 1 ml sodium azide solution (1% w/v) and froze immediately at −80 C for further NMR spectroscopy analysis.
1 H NMR Spectroscopic Analysis of Urine
To analyze the changes of metabolites after the animals were exposed to 5 nm-TiO 2 , NMR was used to analyze the urine samples collected from different time points. 400 l of each urine sample was thoroughly mixed with 200 l deuterated water (D 2 O), then centrifuged at 13,000 g for 10 minutes to remove all precipitates. The supernatant (500 l) was placed in 5 mm NMR tubes and 50 l of a solution of 2,2 ,3,3-deuterotrimethylsilylproprionic acid (TSP) in D 2 O was added (final concentration = 1 mM). The D 2 O and TSP in the tested solution provided the deuterium lock signal for the NMR spectrometer and the chemical shift reference ( 0.0) respectively. 1 H NMR spectra of the urine samples were obtained at 500.13 MHz (298 k, 90 pulse widths) by NMR spectrometer (AVANCE-500 Bruker, Switzerland). The spectral scanning had a scale from 10,000 to 32,000 Hz data points. Acquisition time was 1.638 seconds with relaxation delay of 3 seconds. Water signals were suppressed by a combination of pre-saturation and the data were acquired by the Carr-Purcell-Meiboom-Gill (CPMG) pulse sequence. All data sets were zero-Willed to 64,000 Hz data points, exponential line broadening of 0.3 Hz was applied before Fourier transformation, and the spectra were referenced to the lactate with the chemical shift of 1.33 ppm. TOPSPIN 2.0 was used to the NMR peaks automatic integral within the 0.5-4.5 ppm, each integral interval is 0.005 ppm, then the automatic integral value received was normalized in MS Excel. SIMCA-P 10.0 software was used to do Principle Component Analysis (PCA).
Serum Biochemical Assay
To further evaluate the functional changes of liver and kidney, several serum biochemical indexes, including serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), urea nitrogen (BUN), creatinine (Cr) and creatinine kinase (CK), total protein (Tp), albumin (Alb), blood glucose (Glu), lactate dehydrogenase (LDH) and total cholesterol (TC) were measured at 8 hours and 7 days postexposure. The blood samples were collected via ocular vein (about 0.8 ml each rat), and serum samples were separated by centrifugation (1500 g, 10 min). The levels of ALT, AST, BUN, Cr, CK, Tp, Alb, Glu, LDH a Note: "−8∼0 h" stands for 8 hours before intratracheal instillation. 
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Histopathological Examination
After blood collection, the experimental rats were executed and autopsied, the lungs from all treated groups and control group were collected and immediately fixed in formalin for histopathological examinations. The tissue samples were embedded in paraffin blocks, then sliced and placed on glass slides. After traditional histological hematoxylin-eosin (HE) stain, the slides were observed by optical microscope (CX21FS1, Olympus, Japan). All identifications of slides were blind to the pathologist.
RESULTS AND DISCUSSION
Histopathological Changes in Rats
For the exposure of intratracheal routine, lung must be the first target organ of 5 nm-TiO 2 particles. To exam lung injury and aggregation of the particles after instillation treatment, the lung tissue of experiment rats in three dose groups and controls were subjected to histopathological examination, and the microscopy images are shown in Figure 1 . Aggregation of the TiO 2 particles in lung tissue was dose dependent. No particulate aggregation was found in low dose groups (0.8 mg/kg, Fig. 1(B) ), their lungs did not show any notable pathological changes compare the control group ( Fig. 1(A) ). In the mid-dose group (4 mg/kg, Fig. 1(C) ), sporadically aggregated particles were deposited in gaps and the alveolar cavity of lung tissue. Massive particulate deposition was observed in rats installed with high-dose (20 mg/kg, Fig. 1(D) ) particles. The micrographs also revealed that pulmonary exposures to 5 nm-TiO 2 particles induced expansion of lung gaps (E) and expansion hyperemia (EH) in capillary in the middle and high dose group but not in low dose group. The results of lung pathological examination suggest that the lung damage induced by 5 nm-TiO 2 instillation was dose dependent. When rats were treated with high dose 5 nm-TiO 2 (20 mg/kg) particles, the particles aggregated into larger particles which were embedded in lung tissue for longer periods, provoking more extensive pathological damage in the lung. By contrast, the rats treated with low dose TiO 2 (0.8 mg/kg) did not reveal pulmonary effects because the particles were well scattered and easily migrated to extrapulmonary organs. Chung et al. suggested that smaller size TiO 2 (21 nm) particles could accumulate in lung interstices for longer periods and translocate from the epithelium to neighboring tissues, but the larger particles (120 nm) could not translocate. 26 Nemmar et al.
further showed that the inhalednanoparticles can deposited in alveolar regions and quickly enter the blood via phagocytosis of alveolar macrophages. 27 A recent study further supported that intratracheally instilled nanoparticles could pass through the alveolar capillary barrier into systemic circulation within a 10 minutes with one-compartment kinetic model via AM phagocytosis and macrophage clearance. 8 The extrinsic source nanosized particles in vivo were generally transported to the liver and finally excreted by feces or urine. 28 Subsequently, the normal metabolic function of the liver and kidney may be influenced by particle uptake. Wang's studies show that acute uptake of nano-TiO 2 particles could lead to hepatic inflammation response and renal dysfunction. 4 In Zhu's studies, it was also identified that liver and kidney were the secondary target organs of nanoparticles after intratracheal instillation. The level of endogenous metabolites in urine samples collected from the treatment and control groups at different time intervals were detected by 500 MHz NMR technique, and the 1 HNMR spectra is shown in Figure 2 . Twelve components were selected as metabolic biomarkers (Valine, Acetate, Succinate, 2-Oxoglutarate(2-OG), Citrate, Dimethylamine (DMA), Creatinine, Taurine, Trimethylamine-N-oxide (TMAO), Allantoin, Hippurate1 and Hippurate2) to evaluate the impact caused by 5 nmTiO 2 instillation, and the trend variation of these biomarkers are summarized in Table I .
Principle Component Analysis (PCA) of Pattern Recognition Method was used as a main measure for the analysis of the metabolomics data. We decided to choose the PCA score plots and the PCA loading plot to collect evidence of the variation in urine metabolites (Fig. 3) . For further analysis, two principle components (PC) exhibiting most contribution rate (PC1 and PC2 was 64.7% and 12.1%, respectively) were selected to construct PC plots so as to represent metabolism changes. Figure 3 (a) shows PCA score plots of urine sample collected from 0-8 hours postexposure, and the clustering distribution 
Variations compared to control samples: ↑, indicates relative increase in signal; ↓, relative decrease in signal; -, no change. Keys: s: singlet; d: doublet; t: triplet; m: multiplet. displayed the differences between 5 nm-TiO 2 (low-, midand high-dose, respectively) treated group and control. It indicated that intratracheal instillation of 5 nm-TiO 2 could impact physiological metabolism and impact the level of metabolic products in the urine. In the low dose group, significant elevations of lactate, taurine, acetate, citrate and decrease of 2-OG were found. However, no significant changes were observed in the mid-or high-dose treated groups (p > 0 05). These results suggested that low-dose (0.8 mg/kg) intratracheal instillation of 5 nmTiO 2 could provoke acute alterations of urinary metabolites, but these metabolite changes did not occur in the mid-or high-dose groups.
Lactate is the precursor of the tricarboxylic acid cycle (TCA). Citric acid is an important TCA cycle intermediate, and both citric acid and lactate are closely related to glycolysis and energy metabolic pathway. The TCA cycle is the main way to aerobic metabolism, and those enzymes correlated to catalytic aerobic decomposition of sugar and protein synthesis-related mainly distribute in the mitochondrial matrix. The abnormality of lactate and citrate metabolism may be caused by existence of nano-TiO 2 in lung tissues that reduced the activity of the mitochondrial enzyme. The concentration of citrate in urine is not correlated to its level in blood. When renal tubular acidosis occurs, the level of citrate in urine will be greatly reduced. In this study, the decrease of citrate in urine was also observed in 0.8 mg/kg treated group, implying that renal tubular acidosis may be caused by low-dose nano-TiO 2 .
Changes of taurine, which is a main composition in bile acid, is related to the acute injury of liver. 30 During liver injury (e.g., cholestasis), taurine levels will increase and the excess taurine can be excreted through the urine. As a result, taurine levels in urine can indicate liver damage. 31 Taurine increases in urine were observed only in the low dose group of this study, but not in the middle or high dose groups. This result also implies liver injury can be induced by acute intratracheal instillation of 5 nm-TiO 2 .
Similarly, changes in acetate and 2-OG were only found in the low dose group. Increase levels of acetate, which is a terminal metabolite of purine, indicates damage in the medullary loop of renal tubes. Taurine increases reflect acute liver damage, and the reduction of 2-OG may imply the dysfunction of hepatic energy metabolism. This is due to the fact that 2-OG is one of intermediate product of TAC, which is a main routine for the aerobic metabolism of carbohydrates.
Metabolite changes induced by exposure to low dose 5 nm-TiO 2 were reversible. In the main component analysis of the 1 HNMR spectrum variation value of the urine sample collected from 144-168 hours postexposure, no clustering distribution was observed (Figs. 3(c and d) ). This suggests that metabolic abnormalities caused by 5 nm-TiO 2 exposure were compensatory and those changed biomarkers can revert to normal level within 7 days.
All these results suggest that the intratracheal instillation of 5 nm-TiO 2 is able to acutely disturb the normal metabolic function of the liver and kidney. But metabolic marker alterations were physiological compensatory and recoverable. All the significant changes occurred within 8 hours of exposure, and they recovered and trended to normal levels at the endpoint of the experiment (7 days). These rat urine metabolites fluctuated in rats treated with middle and high doses, but there were no significant changes. It suggested that middle and high dose instillation of 5 nm-TiO 2 can rarely influence the metabolic function of the liver and kidneys.
Serum Biochemical Assay
The results of 1 HNMR analysis of urine metabolites imply that only low dose (0.8 mg/kg) instillations of 5 nm-TiO 2 can acutely impact the metabolic function of the liver and kidneys. The metabolic changes can recover to normal in a short time. To further evaluate the functional changes of the kidney and liver caused by low dose 5 nm-TiO 2 , ten serum biochemical indexes which reflect hepatic and renal function were measured at 8 hours and 7 days post-exposure. The comparison results versus control groups are summarized in Table II. Significant changes were only observed in ALT, BUN and Cr in 8 hours post-exposure, and then recovered to normal levels. The ALT increased to 75 ± 10 3 IU/L at 8 hours post-exposure, implying liver dysfunction. The ALT value recovered to 50 5 ± 9 3 IU/L in 7 days, which was not significant compared to the control (58 1 ± 8 8 IU/L). Similarly, the BUN increased to 9 3 ± 2 4 mmol/L in 8 hours and recovered to 7 50 ± 1 2 mmol/L in 7 days. The Cr level slightly increased to 38 2 ± 4 1 mol/L in 8 hours and came down to 34 8 ± 3 6 mol/L in 7 days. Changes in BUN and Cr are consistent with a recoverable impact on renal function. Other serum biomarkers (Tp, Alb, AST, LDH, CK, GLU and TC) did not have significant changes at 8 hours or 7 days. The results of the serum biochemical assays were consistent with the findings in 1 HNMR analysis. This suggested that instillation of 5 nm-TiO 2 in dose of 0.8 mg/kg did not lead to parenchymal damages in the liver and kidneys, although it impacted hepatic and renal metabolites in urine.
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Tang et al. Dose Dependent In Vivo Metabolic Characteristics of Titanium Dioxide Nanoparticles
Possible Explanation of Dose-Dependent Toxic
Effect Induced by 5 nm-TiO 2
In this study, the abnormalities of hepatic and renal metabolites, induced by intratracheal instillation of 5 nm-TiO 2 , were only observed in the low dose group. We propose that TiO 2 particles in low dose can scatter well in suspension and keep their original nanosize after instillation into the respiratory tract. Other research has shown that particles smaller than 10 nm can rapidly enter the Tp (g/L) 53 1 ± 2 6 5 7 2 ± 6 0 5 5 1 ± 2 3 Alb (g/L) 14 Data are represented as mean ± SD n = 8 , a indicate p < 0 05 versus the control in one-way ANOVA followed by Dunnett's test.
blood circulation and migrate to other organs, translocating to the liver and kidneys as secondary targets. 8 Particulate accumulation in the lung was only observed in the rats that received a low dose instillation, and their liver and kidney function were impacted compared to the control. However, due to the large surface area of the nanoparticle and the high concentration in the high dose group, massive nano-TiO 2 particles may aggregate after instilling into the tracheal and pulmonary environment, although they were well-scattered before intratreacheal instillation. Those particles aggregated into larger size (several micrometers) were hardly phagocytized by alveolar macrophages, and accumulated in lung tissue for a long time (more than 7 days) and provoked a series of pulmonary inflammatory responses like expansion of lung gaps and expansion hyperemia in capillaries. Little nano-TiO 2 migrated to the liver or kidneys, so there were no changes in endogenous hepatic and renal metabolites observed by 1 HNMR detection and no significant changes in blood biochemical assays.
The results of this study imply that the effects of nanoTiO 2 particles are correlated in a dose dependent manner. Whether the particles instilled in lung can migrate from lung to other organs was dependent on the aggregation state of the particles in vivo. High dose instillation only induced pulmonary effects, but low dose treatment impact normal metabolic function of the liver and kidneys. Low dose and long term exposure to nano-TiO 2 would provoke different toxic effects compared to high dose exposures. The results provide useful information concerning metabolic characteristics and secondary targets organ of nano-TiO 2 .
CONCLUSION
Intratracheal instillation of nano-TiO 2 particles (5 nm) can provoke different toxicological effects on lung, liver and kidney, but the target organ and bio-effects of the particles are correlated to dose and in vivo aggregation. The nano-TiO 2 particles can be well scattered and keep their nanosize in the lung when instilled low dose (0.8 mg/kg), and the particles can migrate to the liver and kidneys via blood circulation. Low dose instillation does not induce any lung injury, but impacts the normal metabolic functions of the liver and kidneys, reflected in changes in urine metabolites. These acute metabonomic changes are compensatory and reversible, and the level of the altered metabolites can recover to normal within 7 days. Serum biochemical indices suggest no parenchymal damage in the liver or kidneys. For middle (4 mg/kg) and high dose (20 mg) exposures, due to the huge surface area and high concentration, the particles rapidly aggregate into larger sizes and accumulate in the lung for longer periods (more than 7 days). The aggregated particles can only induce pulmonary inflammation but not impact the function of the liver and kidneys.
